Clinical Trial

The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs
Trial Details
NCT Number NCT06904560
Lead Sponsor Sohag University
Conditions Corneal Diseases
Enrollment 40 participants
Start Date 2025-04-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-01